Current Vascular Pharmacology is a premier academic journal published by Bentham Science Publications Ltd, focusing on the intersection of pharmacology and cardiovascular medicine. With an impact factor that reflects its significance in the field, this journal ranks in the Q1 category for both Pharmacology and Cardiology, showcasing its dedication to high-quality research. Its Scopus ranks place it in the top percentile of its categories, highlighting its influence among scholars and practitioners alike. Issued since 2003 and continuing through 2024, Current Vascular Pharmacology aims to disseminate cutting-edge findings and foster knowledge exchange among researchers, professionals, and students engaged in cardiovascular pharmacology. Despite being a subscription-based journal, it remains a vital resource for those seeking the latest advancements in drug development and therapeutic interventions for vascular diseases. Located in the United Arab Emirates, the journal serves as an essential platform for global discourse on vascular health.

Journal of Endovascular Therapy, published by SAGE Publications Inc., has established itself as a leading source of research and innovation in the fields of Cardiology, Cardiovascular Medicine, Radiology, and Surgery. With an impressive impact factor and recognized in the Q1 quartile for its contributions, this journal is essential for professionals and researchers dedicated to advancing the practice of endovascular therapy. The journal, which has been in circulation since 2000, covers a wide range of topics pertinent to endovascular procedures and therapeutics, offering valuable insights and findings that drive clinical practice and enhance patient outcomes. With its emphasis on high-quality peer-reviewed content, the Journal of Endovascular Therapy serves as a vital resource for both established experts and emerging scholars in the medical community. Access to the journal is facilitated for a wider audience, ensuring that innovative research reaches practitioners and academics worldwide, fostering an environment of collaboration and knowledge exchange.

ANNALS OF VASCULAR SURGERY is a premier journal published by Elsevier Science Inc, focusing on the rapidly evolving field of vascular surgery and its related disciplines. With a notable impact factor reflected in its 2023 Q2 rankings in Cardiology and Cardiovascular Medicine, as well as in Medicine and Surgery, this journal stands out as a reputable source for cutting-edge research and clinical practices. Since its inception in 1986, it has aimed to advance knowledge, foster innovation, and enhance surgical techniques through comprehensive reviews, original research articles, and clinical trials. Although not currently adopting an open access model, the journal continues to serve as a crucial repository of information for researchers, clinicians, and students, facilitating the dissemination of clinical and scientific advancements in vascular health. As it converges through the years towards 2024, the ANNALS OF VASCULAR SURGERY is poised to remain a valuable resource for the global medical community.

PHLEBOLOGY is a renowned academic journal published by SAGE Publications Inc. that focuses on the evolving field of phlebology and related cardiovascular issues. With an ISSN of 0268-3555 and an E-ISSN of 1758-1125, this journal serves as a pivotal platform for disseminating high-quality research, clinical findings, and innovative practices in venous disease management and treatment. Operating from the United Kingdom, tasked with a mission to advance the scientific understanding and clinical practice surrounding venous disorders, PHLEBOLOGY is currently ranked in the Q3 category for both Cardiology and Cardiovascular Medicine, as well as in Medicine (miscellaneous) for 2023. Its Scopus rank of #192 out of 387 highlights its commitment to excellence, ensuring that it reaches a respectable 50th percentile within its fields. Although it does not offer open access, the journal invites contributions from researchers, healthcare professionals, and students, fostering a community dedicated to improving patient outcomes and promoting evidence-based practices in venous health.

JRSM Cardiovascular Disease is a leading open-access journal published by SAGE Publications Ltd, dedicated to promoting research and knowledge dissemination in the vital field of cardiovascular health. Established in 2012, the journal plays a pivotal role in advancing the understanding of cardiovascular diseases through peer-reviewed articles, clinical studies, and innovative research findings. With a focus on enhancing patient care and public health, it aims to bridge the gap between research and practice, making it an essential resource for researchers, healthcare professionals, and students alike. By facilitating open access to its content, JRSM Cardiovascular Disease ensures that significant discoveries and advancements are available to a global audience, thereby contributing to the ongoing dialogue and collaboration within the cardiovascular disease community. This journal not only highlights critical advancements but also fosters an environment for continuous education and improvement in the field.

The European Journal of Vascular and Endovascular Surgery, published by W B Saunders Co Ltd, is a leading academic periodical in the fields of cardiology and surgery, boasting an impressive impact factor thanks to its high-quality peer-reviewed studies and clinical insights. With a publication history spanning from 1995 to 2024, this journal consistently ranks in the Q1 category for both Cardiology and Cardiovascular Medicine and Surgery, demonstrating its significance and influence in the medical community. Furthermore, it holds respectable positions in Scopus Ranks, being ranked #28 out of 551 in Medicine & Surgery and #72 out of 387 in Medicine & Cardiology, placing it in the top 95th and 81st percentiles respectively. While not an Open Access journal, the wealth of knowledge it offers is vital for researchers, healthcare professionals, and students dedicated to advancing vascular and endovascular surgical practices. Accessing this journal allows for the exploration of innovative methodologies and the latest developments in the management of vascular diseases, ensuring that readers remain at the forefront of their fields.

Diabetes & Vascular Disease Research is a leading academic journal dedicated to advancing the understanding and treatment of cardiovascular and metabolic diseases, particularly diabetes. Published by SAGE Publications Ltd in the United Kingdom, this journal serves as a key resource for researchers, clinicians, and students seeking to explore the intricate relationship between diabetes and vascular health. With an impressive Impact Factor and ranked in the Q2 quartile in prominent categories such as Cardiology, Endocrinology, and Internal Medicine, the journal provides a platform for high-quality, peer-reviewed research. Covering a broad range of topics from pathophysiology to therapeutic innovations, Diabetes & Vascular Disease Research plays a vital role in shaping contemporary discourse in the field. With contributions from leading experts and a commitment to disseminating valuable findings, this journal is a must-read for anyone involved in the fight against vascular complications arising from diabetes.

PHLEBOLOGIE is an esteemed journal published by GEORG THIEME VERLAG KG, serving as a critical platform for the dissemination of research in the field of Cardiology and Cardiovascular Medicine. Since its inception in 1991, the journal has consistently provided a comprehensive range of articles that explore the complexities of vascular health, offering insights into innovative treatments, diagnostic advancements, and emerging trends. Although currently not available as an Open Access publication, PHLEBOLOGIE maintains an impactful presence in the academic community, evident in its 2023 Scopus ranking as Q3 within its category and a percentile standing of 25%. Residing in Germany, PHLEBOLOGIE aims to bridge the gap between research and practice, appealing to researchers, clinicians, and students alike by fostering a deeper understanding of vascular conditions and their management.

Acta Angiologica, published by VIA MEDICA, is an Open Access journal dedicated to the dynamic field of cardiology and cardiovascular medicine. Since its inception in 1995, this esteemed journal has provided a vital platform for the dissemination of cutting-edge research and innovative medical practices, especially pertinent to vascular health. Being indexed in Scopus, it holds a rank of #352 out of 387 in its category for 2023, positioning it in the 9th percentile among contemporaneous journals. The journal's commitment to scholarly excellence and accessibility is underscored by its embrace of open access publishing, allowing researchers, professionals, and students to engage with vital advancements in the field without financial barriers. With a converged timeline from 2005 to 2024, Acta Angiologica continues to play a crucial role in bridging gaps in cardiovascular knowledge, fostering collaboration across disciplines, and advancing the implementation of preventative and therapeutic strategies in vascular medicine. Located in Gdansk, Poland, the journal is poised to make significant contributions to the cardiovascular research landscape.

Gefasschirurgie, a leading journal published by Springer Heidelberg, serves as a pivotal resource in the fields of surgery and cardiology with a robust focus on vascular surgery. With its ISSN 0948-7034 and E-ISSN 1434-3932, the journal provides a platform for the dissemination of innovative research findings, clinical practices, and advancements in minimally invasive procedures, aimed at improving patient outcomes. Established in 1996 and expected to continue until 2024, *Gefasschirurgie* has built a considerable reputation in both the surgical and cardiovascular medicine communities. Although currently categorized in Q4 for Cardiology and Cardiovascular Medicine and Q3 for Surgery, the journal's commitment to publishing high-quality, peer-reviewed research helps advance the understanding and treatment of vascular conditions. It is essential for professionals, researchers, and students aiming to stay abreast of new techniques, clinical trials, and surgical methods in the evolving landscape of vascular health.